Cibus Inc. (CBUS)
NASDAQ (CM) NASDAQ (CM) Primary 
Cibus, Inc. (CBUS) Q2 2026 Earnings Call Transcript
Cibus, Inc. (CBUS) Q2 2026 Earnings Call Transcript
Cibus (CBUS) Reports Q2 Loss, Misses Revenue Estimates
Cibus (CBUS) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.61 per share a year ago.
Cibus Q2 Earnings Call Highlights
Cibus NASDAQ: CBUS reported second-quarter 2026 revenue of $1.0 million, compared with $0.9 million a year earlier, as the agricultural biotechnology company advanced its Sustainable Ingredients program and updated the expected timing of its initial rice launch in Latin America.
Cibus, Inc. (CBUS) Q1 2026 Earnings Call Transcript
Cibus, Inc. (CBUS) Q1 2026 Earnings Call Transcript
Cibus (CBUS) Reports Q1 Loss, Beats Revenue Estimates
Cibus (CBUS) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to a loss of $0.74 per share a year ago.
Cibus Q1 Earnings Call Highlights
Cibus NASDAQ: CBUS reported first-quarter 2026 results and said it is advancing toward commercialization across its rice and sustainable ingredients programs, while also reducing expenses and extending its cash runway into late in the first quarter of 2027.
Cibus (CBUS) Upgraded to Buy: What Does It Mean for the Stock?
Cibus (CBUS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Cibus, Inc. (CBUS) Q4 2025 Earnings Call Transcript
Cibus, Inc. (CBUS) Q4 2025 Earnings Call Transcript
Cibus (CBUS) Reports Q4 Loss, Lags Revenue Estimates
Cibus (CBUS) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to a loss of $0.87 per share a year ago.
Cibus, Inc. (CBUS) Q3 2025 Earnings Call Transcript
Cibus, Inc. ( CBUS ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Carlo Broos - Chief Financial Officer Peter Beetham - Co-Founder, Interim CEO, President, COO & Director Gregory Gocal - Co-Founder, Chief Scientific Officer & Executive VP Conference Call Participants Kevin Estok - Jefferies LLC, Research Division Matthew Venezia - Alliance Global Partners, Research Division Sameer Joshi - H.C. Wainwright & Co, LLC, Research Division Austin Moeller - Canaccord Genuity Corp., Research Division Alex Hantman - Sidoti & Company, LLC Presentation Operator Good afternoon, everyone, and welcome to the Cibus Third Quarter 2025 Results Conference Call.
Cibus (CBUS) Reports Q3 Loss, Misses Revenue Estimates
Cibus (CBUS) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to earnings of $0.06 per share a year ago.
Cibus, Inc. (CBUS) Q2 2025 Earnings Call Transcript
Cibus, Inc. (NASDAQ:CBUS ) Q2 2025 Earnings Conference Call August 14, 2025 4:30 PM ET Company Participants Cornelis Broos - Interim Chief Financial Officer Gregory F. Gocal - Co-Founder, Chief Scientific Officer & Executive VP Peter R.
